Equities

Cosmo Pharmaceuticals NV

Cosmo Pharmaceuticals NV

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (CHF)83.70
  • Today's Change-1.30 / -1.53%
  • Shares traded7.81k
  • 1 Year change+13.72%
  • Beta1.5952
Data delayed at least 15 minutes, as of Apr 09 2021 16:35 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Friday, Cosmo Pharmaceuticals NV (COPN:SWX) closed at 83.70, 18.56% above the 52 week low of 70.60 set on Apr 15, 2020.
52-week range
Today
70.60Apr 15 202097.30Aug 31 2020
Markit short selling activity
Low
Med
High
Open84.90
High84.90
Low83.00
Bid81.00
Offer84.80
Previous close85.00
Average volume10.20k
Shares outstanding15.04m
Free float7.49m
P/E (TTM)--
Market cap1.26bn CHF
EPS (TTM)-0.6008
CHF
Data delayed at least 15 minutes, as of Apr 09 2021 16:35 BST.
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.